🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 75955J402
- Market Cap
- Small Cap
- Previous Symbol
- RLMDD
Business: Relmada Therapeutics, Inc. is a clinical-stage biotechnology company developing REL-1017 (dextromethadone) in multiple indications. RELM-1017 is in Phase 2 for treatment resistant depression and preclinical testing for additional indications.
Company Contact
- CEO
- Sergio Traversa
- CFO
- Maged Shenouda
- Headquarters
- 2222 Ponce de Leon, Floor 3, Coral Gables, FL
- Phone
- 786-629-1376
- Investor Relations
- Sergio Traversa · 646-876-3459 · straversa@relmada.com